These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11588030)

  • 1. Allogeneic transplantation of CD34(+) selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34(+) cells?
    Urbano-Ispizua A; Carreras E; Marín P; Rovira M; Martínez C; Fernández-Avilés F; Xicoy B; Hernández-Boluda JC; Montserrat E
    Blood; 2001 Oct; 98(8):2352-7. PubMed ID: 11588030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings.
    Urbano-Ispizua A; Rozman C; Pimentel P; Solano C; de la Rubia J; Brunet S; Pérez-Oteiza J; Ferrá C; Zuazu J; Caballero D; Carvalhais A; Díez JL; Espigado I; Martínez C; Campilho F; Sanz MA; Sierra J; García-Conde J; Montserrat E;
    Blood; 2001 Jan; 97(2):383-7. PubMed ID: 11154212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold?
    Singhal S; Powles R; Treleaven J; Kulkarni S; Sirohi B; Horton C; Millar B; Shepherd V; Tait D; Saso R; Rowland A; Long S; Mehta J
    Bone Marrow Transplant; 2000 Sep; 26(5):489-96. PubMed ID: 11019837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
    Bensinger WI; Buckner CD; Shannon-Dorcy K; Rowley S; Appelbaum FR; Benyunes M; Clift R; Martin P; Demirer T; Storb R; Lee M; Schiller G
    Blood; 1996 Dec; 88(11):4132-8. PubMed ID: 8943847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
    Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
    Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
    Briones J; Urbano-Ispizua A; Lawler M; Rozman C; Gardiner N; Marín P; Salgado C; Féliz P; McCann S; Montserrat E
    Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies.
    Mavroudis D; Read E; Cottler-Fox M; Couriel D; Molldrem J; Carter C; Yu M; Dunbar C; Barrett J
    Blood; 1996 Oct; 88(8):3223-9. PubMed ID: 8874224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies.
    Cornelissen JJ; van der Holt B; Petersen EJ; Vindelov L; Russel CA; Höglund M; Maertens J; Schouten HC; Braakman E; Steijaert MM; Zijlmans MJ; Slaper-Cortenbach I; Boogaerts MA; Löwenberg B; Verdonck LF
    Exp Hematol; 2003 Oct; 31(10):855-64. PubMed ID: 14550800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation.
    Zaucha JM; Gooley T; Bensinger WI; Heimfeld S; Chauncey TR; Zaucha R; Martin PJ; Flowers ME; Storek J; Georges G; Storb R; Torok-Storb B
    Blood; 2001 Dec; 98(12):3221-7. PubMed ID: 11719357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor.
    Kawano Y; Takaue Y; Watanabe A; Takeda O; Arai K; Itoh E; Ohno Y; Teshima T; Harada M; Watanabe T; Okamoto Y; Abe T; Kajiume T; Matsushita T; Ikeda K; Endo M; Kuroda Y; Asano S; Tanosaki R; Yamaguchi K; Law P; McMannis JD
    Blood; 1998 Nov; 92(9):3123-30. PubMed ID: 9787147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies.
    Bahçeci E; Read EJ; Leitman S; Childs R; Dunbar C; Young NS; Barrett AJ
    Br J Haematol; 2000 Feb; 108(2):408-14. PubMed ID: 10691874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogenic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia.
    Mavroudis DA; Read EJ; Molldrem J; Raptis A; Plante M; Carter CS; Phang S; Dunbar CE; Barrett AJ
    Bone Marrow Transplant; 1998 Mar; 21(5):431-40. PubMed ID: 9535034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants.
    Rocha V; Carmagnat MV; Chevret S; Flinois O; Bittencourt H; Esperou H; Garnier F; Ribaud P; Devergie A; Socié G; Dal'Cortivo L; Marolleau JP; Charron D; Gluckman E; Rabian C
    Exp Hematol; 2001 Nov; 29(11):1347-52. PubMed ID: 11698131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation.
    Martin PS; Li S; Nikiforow S; Alyea EP; Antin JH; Armand P; Cutler CS; Ho VT; Kekre N; Koreth J; Luckey CJ; Ritz J; Soiffer RJ
    Haematologica; 2016 Apr; 101(4):499-505. PubMed ID: 26768686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT.
    Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteiza J; Jurado M; Oyonarte S; Sierra J; García-Conde J; Rozman C
    Bone Marrow Transplant; 1998 Sep; 22(6):519-25. PubMed ID: 9758337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation.
    Urbano-Ispizua A; Brunet S; Solano C; Moraleda JM; Rovira M; Zuazu J; de La Rubia J; Bargay J; Caballero D; Díez-Martín JL; Ojeda E; Pérez de Oteiza JP; Ferrá C; Espigado I; Alegre A; de La Serna J; Torres P; Riu C; Odriozola J; Rozman C; Sierra J; García-Conde J; Montserrat E;
    Bone Marrow Transplant; 2001 Aug; 28(4):349-54. PubMed ID: 11571506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism.
    Beelen DW; Ottinger HD; Elmaagacli A; Scheulen B; Basu O; Kremens B; Havers W; Grosse-Wilde H; Schaefer UW
    Blood; 1997 Dec; 90(12):4725-35. PubMed ID: 9389688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.